These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2550538)

  • 21. 5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats.
    Blessing WW; Seaman B
    Neuroscience; 2003; 117(4):939-48. PubMed ID: 12654345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the neuropeptide YY1 receptor antagonist SR 120107A on sympathetic vascular control in pigs in vivo .
    Malmström RE; Lundberg JM
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):633-42. PubMed ID: 8938663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional haemodynamic effects of carbachol injected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats.
    Bachelard H; Gardiner SM; Kemp PA; Bennett T
    Neuropharmacology; 1994 Jun; 33(6):769-88. PubMed ID: 7936115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of neuropeptide Y and noradrenaline mechanisms in sympathetic control of pig spleen.
    Lundberg JM; Rudehill A; Sollevi A
    Eur J Pharmacol; 1989 Apr; 163(1):103-13. PubMed ID: 2744085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
    Pernow J; Saria A; Lundberg JM
    Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NPY is not a primary mediator of the acute thyroid blood flow response to sympathetic nerve stimulation.
    Dey M; Michalkiewicz M; Huffman L; Hedge GA
    Am J Physiol; 1993 Jul; 265(1 Pt 1):E24-30. PubMed ID: 8338150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
    Pernow J; Lundberg JM; Kaijser L
    J Cardiovasc Pharmacol; 1988; 12(5):593-9. PubMed ID: 2468060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
    Lacroix JS
    Acta Physiol Scand Suppl; 1989; 581():1-63. PubMed ID: 2568728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats.
    Gardiner SM; Compton AM; Bennett T
    Br J Pharmacol; 1990 Jan; 99(1):107-12. PubMed ID: 2139584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of pressor response to posterior hypothalamic injection of neuropeptide Y.
    Martin JR; Knuepfer MM; Beinfeld MC; Westfall TC
    Am J Physiol; 1989 Sep; 257(3 Pt 2):H791-8. PubMed ID: 2782438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
    Clarke J; Benjamin N; Larkin S; Webb D; Maseri A; Davies G
    Circulation; 1991 Mar; 83(3):774-7. PubMed ID: 1999028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y.
    Modin A; Pernow J; Lundberg JM
    Acta Physiol Scand; 1993 May; 148(1):1-11. PubMed ID: 8333291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
    Hieble JP; Duesler JG; Daly RN
    J Pharmacol Exp Ther; 1989 Aug; 250(2):523-8. PubMed ID: 2668503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cervical sympathetic nerve stimulation and neuropeptide Y (NPY) on cranial blood flow in the cat.
    Granstam E; Nilsson SF
    Acta Physiol Scand; 1991 May; 142(1):21-32. PubMed ID: 1877362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similarities and differences in the postjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature.
    Owen MP
    J Pharmacol Exp Ther; 1993 May; 265(2):887-95. PubMed ID: 8496832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of NPY Y1 receptors in cardiovascular control in the conscious rabbit.
    Serone AP; Wright CE; Angus JA
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):315-21. PubMed ID: 10672867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors.
    Donoso MV; Brown N; Carrasco C; Cortes V; Fournier A; Huidobro-Toro JP
    J Neurochem; 1997 Sep; 69(3):1048-59. PubMed ID: 9282927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
    Awad SJ; Einstein R; Potter EK; Richardson DP
    Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.